Evidation Health, a technology company that provides clinical validation of digital health apps for the benefit of payers, providers and health systems, has raised $11.6 million in a new financing round, according to a Form D filing with the U.S. Securities and Exchange Commission.
It marks the first healthcare investment by B Capital Group, a venture capital firm started last year by Facebook co-founder Eduardo Saverin and former Boston Consulting Group senior adviser Raj Ganguly, according to its website.
Healthcare is one of its investment targets, specifically: “Connected products and platforms that take a holistic and tailored approach to health and wellness, enabling informed choices.” The investment firm, which has offices in Singapore, San Francisco and Los Angeles, raised more than $143 million in the first close for its first fund last month, The Wall Street Journal reported.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Evidation Health declined to comment about the new funding as this story was posted.
The latest fundraise follows a Series A round in March last year. GE Ventures, Stanford Health Care and Asset Management Ventures are among the established investors in the business, previously known as Activity Exchange.
Last year, Evidation partnered with Ochsner Health System, a New Orleans Health System known for its O Bar app engagement portal. It also inked a collaboration deal with PokitDok to help Evidation access claims data and technologies developed by PokitDok. After obtaining patient consent, it can use their claims data to evaluate digital health interventions, clinical and economic outcomes.
Photo: Flickr user Keith Cooper